Centaurus Financial, Inc. Haleon PLC Transaction History

Centaurus Financial, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	SELL	$7.57 - $8.37 $19,182 - $21,209	-2,534 Reduced 20.05%	10,102 $82,000
Q4 2022 Feb 10, 2023	SELL	$5.96 - $8.06 $1,037 - $1,402	-174 Reduced 1.36%	12,636 $101,000
Q3 2022 Dec 05, 2022	BUY	$5.63 - $7.5 $72,120 - $96,075	12,810 New	12,810 $78,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.